Cargando…
Diabetic retinopathy: Involved cells, biomarkers, and treatments
Diabetic retinopathy (DR), a leading cause of vision loss and blindness worldwide, is caused by retinal neurovascular unit dysfunction, and its cellular pathology involves at least nine kinds of retinal cells, including photoreceptors, horizontal and bipolar cells, amacrine cells, retinal ganglion c...
Autores principales: | Ren, Jiahui, Zhang, Shuxia, Pan, Yunfeng, Jin, Meiqi, Li, Jiaxin, Luo, Yun, Sun, Xiaobo, Li, Guang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396039/ https://www.ncbi.nlm.nih.gov/pubmed/36016568 http://dx.doi.org/10.3389/fphar.2022.953691 |
Ejemplares similares
-
Epac: A Promising Therapeutic Target for Vascular Diseases: A Review
por: Pan, Yunfeng, et al.
Publicado: (2022) -
Single-cell RNA sequencing in atherosclerosis: Mechanism and precision medicine
por: Li, Qiaoyu, et al.
Publicado: (2022) -
Exosomes in pathogenesis, diagnosis, and therapy of ischemic stroke
por: Jin, Meiqi, et al.
Publicado: (2022) -
Senolytics in the treatment of diabetic retinopathy
por: Hassan, Jannah Waled, et al.
Publicado: (2022) -
Noncoding RNAs Are Promising Therapeutic Targets for Diabetic Retinopathy: An Updated Review (2017–2022)
por: Wang, Mengchen, et al.
Publicado: (2022)